OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial Pharmaceutical Investing
Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market Medical Device Investing
Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808 Pharmaceutical Investing
Arch Biopartners Receives Approval to Perform Phase I Clincial Trial for Metablok in Australia Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
